Log-in
Sign-up
Webcast
Clinical Trials
Library
Webcast
Clinical Trials
Library
Home
>
Clinical Trials
Molecules
전체
Edoxaban
Olmesartan
Prasugrel
Pravastatin
Mirogabalin
Ramosetron
Trastuzumab deruxtecan
Status
Select
Check All
Search
Recruiting
Completed
Not yet recruiting
Enrolling by invitation
Active, not recruiting
Suspended
Terminated
Withdrawn
Unknown status
Email
Saved trials
RECRUITING
NCT05491200
Comparison Of Reduced DAPT Followed by P2Y12 Inhibitor Monotherapy With Prasugrel vs stAndard Regimen in STEMI Patients
1,656
Enrollment(s)
27
Study location(s)
INTERVENTIONAL (PHASE4)
ST Elevated Myocardial Infarction
Dual Antiplatelet Therapy
ACTIVE_NOT_RECRUITING
NCT03127631
A Study for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients
5,000
Enrollment(s)
61
Study location(s)
INTERVENTIONAL (NA)
Prostate Cancer
Cardiovascular Disease
RECRUITING
NCT06630130
Perioperative Therapies in Locally Advanced Unresectable Gastric Cancer
100
Enrollment(s)
1
Study location(s)
INTERVENTIONAL (PHASE2)
Stomach Neoplasms
RECRUITING
NCT05376878
An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brain Metastasis
10
Enrollment(s)
1
Study location(s)
INTERVENTIONAL (PHASE4)
Anatomic Stage IV Breast Cancer AJCC v8
Metastatic Breast Carcinoma
Metastatic Malignant Neoplasm in the Brain
ACTIVE_NOT_RECRUITING
NCT04488822
A Study of the Efficacy and Safety of Pexidartinib in Adult Subjects With TGCT
40
Enrollment(s)
9
Study location(s)
INTERVENTIONAL (PHASE3)
Tenosynovial Giant Cell Tumor
RECRUITING
NCT07157852
The Efficacy and Safety of Pregabalin and Mirogabalin in Patients With Fibromyalgia
674
Enrollment(s)
1
Study location(s)
INTERVENTIONAL (NA)
Fibromyalgia
Pregabalin
Mirogabalin
Pain
COMPLETED
NCT04703322
A Study of Pexidartinib in Tenosynovial Giant Cell Tumor in Japan
9
Enrollment(s)
6
Study location(s)
INTERVENTIONAL (PHASE2)
Tenosynovial Giant Cell Tumor
NOT_YET_RECRUITING
NCT07662473
The Efficacy and Safety of Trastuzumab Deruxtecan in Advanced or Metastatic NSCLC With HER2 Over Expression
30
Enrollment(s)
1
Study location(s)
INTERVENTIONAL (PHASE2)
NSCLC
11
12
13
14
15